Skip to Main Content

Paper Details

Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer.
Sci Rep
36
2021
CRPC, Niclosamide, PDMX1001, PSA, Patients, Prostate Cancer, abiraterone, androgen, androgen receptor variant 7, cancers, castration-resistant prostate cancer, diarrhea, ketoconazole, men, niclosamide, patients, prednisone, prostate cancer
Author NameAffiliation
Christopher P EvansUniversity of California davis
Primo N LaraUniversity of California davis
Neeraj AgarwalHuntsman Cancer Institute, University of Utah
  • 1 - 3

Datasets

Release 1.2